Fintel reports that on May 3, 2024, B of A Securities initiated coverage of Avidity Biosciences (NasdaqGM:RNA) with a Buy ...

This week, I crunched some performance numbers for biotech PIPES, and chatted with the CEO of Benitec Biopharma about its ...

I write about shareholder democracy, corporate governance and activist investing. Avoro is a highly credible activist investor, having pushed for the October 2020 acquisition of Immunomedics ...

What are Other Shareholders Doing? Avoro Capital Advisors holds 1,660K shares representing 9.08% ownership of the company. In it's prior filing, the firm reported owning 1,535K shares ...

Avoro Capital Advisors, Axiom Real-Time Metrics, Baptist Health System, Bayer, BeiGene, BioCity Biopharma, Blueprint Medicines, Boxer Capital, BridGene Biosciences, Bristol Myers Squibb ...

The round was led by Access Biotechnology, with new investors Deep Track Capital, Avoro Ventures, Invus, Rock Springs Capital, and Maj Invest Equity, joining in along with current backers Novo ...

The firm increased its portfolio allocation in MDGL by 298.77% over the last quarter. Avoro Capital Advisors holds 1,889K shares representing 9.00% ownership of the company. In it's prior filing ...

Incidente mortale sul lavoro a Gioia del Colle, nel barese, dove un operaio di 59 anni ha perso la vita. Da accertare con ...

Intesa Sanpaolo nel suo museo delle Gallerie d’Italia di Torino offre al pubblico fino al 1 settembre 2024 la mostra ...

Soleus Capital was flat in March but remains up 14 percent for the year. And Avoro Capital Advisors is up 14.4 percent even after dropping 40 basis points in March. Averill Partners, part of ...

Il presidente della Repubblica in occasione del primo maggio: 'Non è una merce, non possiamo accettare stillicidio morti' ...

At dinner, to my left, was Biogen CEO Chris Viehbacher; to my right, Avoro Capital’s Behzad Aghazadeh. I sat directly across from Novo Nordisk scientist Lotte Knudsen. AstraZeneca’s cancer R&D ...